In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species

Abstract Micafungin (MCFG) is an echinocandin antifungal agent that exhibits potent activity against most species of Candida and Aspergillus . We investigated the in vitro antifungal combination effects of MCFG with four other antifungal agents — fluconazole (FLCZ), voriconazole (VRCZ), amphotericin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2009-02, Vol.15 (1), p.1-5
Hauptverfasser:	Nishi, Isao, Sunada, Atsuko, Toyokawa, Masahiro, Asari, Seishi, Iwatani, Yoshinori
Format:	Artikel
Sprache:	eng
Schlagworte:	Amphotericin B Amphotericin B - pharmacology Antifungal Agents - pharmacology Aspergillus Candida Candida - drug effects Candida glabrata Candidiasis - microbiology Combination effect Drug Synergism Echinocandins - pharmacology Fluconazole Fluconazole - pharmacology Flucytosine - pharmacology Hematology, Oncology and Palliative Medicine Humans Infectious Diseases Lipopeptides - pharmacology Medical Microbiology Medicine & Public Health Micafungin Original Article Pyrimidines - pharmacology Triazoles - pharmacology Virology Voriconazole
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!